Home / Inspections / 1008821

FDA Inspection 1008821 — Eurofins Biopharma Product Testing Ireland Limited

Eurofins Biopharma Product Testing Ireland Limited — FEI 3002807550

The FDA completed an inspection of Eurofins Biopharma Product Testing Ireland Limited on February 24, 2017 in Dungarvan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 24, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dungarvan (Ireland)

Facility

Other inspections at this facility

  • 1280309 (NAI Fri Jun 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1270954 (VAI Fri May 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 826551 (NAI Fri Mar 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 618581 (NAI Wed Sep 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources